VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...

Rakovina Therapeutics Inc. , a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, announces continued advancement of its AI-driven drug discovery program.

Orange County's elected leaders and UNC's chancellor shared their reactions to the threat of halted federal funding by ...

Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to abortion pills has significantly increased, including among those living in ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Background Uncertainty is defined as limited knowledge or lack of predictability about past, present or future events. The ...